ReviewCommunications medicine2026
Connectomic signatures advance the understandings of transdiagnostic heterogeneity in psychosis.
Review in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current consensus-driven diagnostic systems poorly capture the marked heterogeneity and high comorbidity of psychiatric disorders, necessitating brain-based transdiagnostic frameworks to advance mechanistic understanding and clinical translation. Connectome-wide association studies have consistently identified widespread large-scale dysconnectivity across diagnostic boundaries, yet normative modeling and meta-analytic evidence highlights substantial inter-individual variability in the spatial topography and magnitude of connectomic deviations. In this Perspective, we bridge this divide between cross-disorder commonalities and individualized pathology by integrating connectomic overlap and computational biotyping into a top-down, four-tiered hierarchical architecture. This framework progresses from macro-scale transdiagnostic topological scaffolds, through meso-scale phenotypic triangulation, to data-driven biotypes and micro-scale clinical translations, delineating bidirectional interplay between shared network constraints and heterogeneous pathological diversification. Building on this architecture, we outline strategies leveraging multi-cohort data harmonization and healthy-anchored normative biotyping to refine robust cross-disorder circuits and reproducible neurobiotypes. Lastly, we propose a translational roadmap to transition connectomic stratification toward prospective, treatment-relevant clinical validation in precision psychiatry.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.